BUSPIRONE HYDROCHLORIDE

BUSPIRONE HYDROCHLORIDE was reported 11351 times

BUSPIRONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FEAR OF CROWDED PLACES 9 0.1343
1 NOCTURNAL FEAR 11 0.0791
2 SOCIAL FEAR 9 0.0484
3 PRE-EXISTING CONDITION IMPROVED 134 0.0214
4 INFUSION SITE DISCHARGE 34 0.0194
5 PRODUCT ADMINISTRATION INTERRUPTED 152 0.0193
6 CATAPLEXY 25 0.0176
7 SLEEP-RELATED EATING DISORDER 11 0.0117
8 OBSTRUCTIVE SLEEP APNOEA SYNDROME 16 0.0110
9 INFUSION SITE DISCOMFORT 11 0.0106
10 HYPOPARATHYROIDISM 8 0.0104
11 GENERALISED ANXIETY DISORDER 15 0.0102
12 NARCOLEPSY 19 0.0101
13 INFUSION SITE NODULE 9 0.0094
14 INFUSION SITE WARMTH 11 0.0090
15 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 12 0.0089
16 INFUSION SITE PRURITUS 28 0.0089
17 INFUSION SITE HAEMORRHAGE 29 0.0088
18 ALLERGIC SINUSITIS 7 0.0082
19 ALCOHOL WITHDRAWAL SYNDROME 7 0.0080
20 POST-TRAUMATIC STRESS DISORDER 51 0.0076
21 INFUSION SITE MASS 8 0.0074
22 INFUSION SITE REACTION 22 0.0074
23 SLEEP APNOEA SYNDROME 140 0.0073
24 INFUSION SITE IRRITATION 9 0.0070
25 SOMNAMBULISM 46 0.0070
26 INFUSION SITE PAIN 90 0.0070
27 ANTICHOLINERGIC SYNDROME 11 0.0069
28 INFUSION SITE ERYTHEMA 57 0.0068
29 INFUSION SITE INDURATION 10 0.0067
30 INFUSION SITE SWELLING 42 0.0067
31 INFUSION SITE RASH 9 0.0066
32 CATHETER SITE PAIN 17 0.0065
33 POST-ACUTE COVID-19 SYNDROME 8 0.0065
34 INFUSION SITE INFECTION 15 0.0064
35 DEVICE INFUSION ISSUE 16 0.0064
36 HYPOTONIA NEONATAL 10 0.0064
37 SEROTONIN SYNDROME 123 0.0064
38 VASCULAR DEVICE INFECTION 29 0.0064
39 CYSTITIS INTERSTITIAL 10 0.0062
40 SLEEP PARALYSIS 9 0.0061
41 INFUSION SITE BRUISING 13 0.0060
42 SEASONAL ALLERGY 84 0.0059
43 BIPOLAR I DISORDER 13 0.0059
44 EYELID PAIN 12 0.0059
45 BILIARY DYSKINESIA 10 0.0059
46 MAST CELL ACTIVATION SYNDROME 8 0.0057
47 HANGOVER 20 0.0057
48 CATHETER SITE ERYTHEMA 12 0.0056
49 BIPOLAR DISORDER 60 0.0055
50 COMPLEX REGIONAL PAIN SYNDROME 8 0.0054
51 SNORING 20 0.0053
52 DRUG TITRATION ERROR 13 0.0050
53 CHRONIC FATIGUE SYNDROME 7 0.0050
54 GLUTEN SENSITIVITY 7 0.0049
55 BRUXISM 26 0.0048
56 RHINITIS ALLERGIC 21 0.0047
57 DIABETIC NEUROPATHY 23 0.0046
58 GASTRIC BYPASS 10 0.0046
59 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19 0.0045
60 MULTIPLE ALLERGIES 34 0.0043
61 CARDIOVASCULAR INSUFFICIENCY 7 0.0043
62 INITIAL INSOMNIA 44 0.0043
63 HYPERPHAGIA 17 0.0043
64 INSURANCE ISSUE 65 0.0042
65 HYPERVOLAEMIA 21 0.0042
66 INCORRECT DRUG ADMINISTRATION RATE 18 0.0042
67 ENURESIS 17 0.0042
68 OXYGEN CONSUMPTION INCREASED 10 0.0042
69 MOTION SICKNESS 8 0.0041
70 AUTONOMIC NERVOUS SYSTEM IMBALANCE 12 0.0041
71 NASAL SEPTUM DEVIATION 8 0.0041
72 ACUTE SINUSITIS 7 0.0041
73 MYDRIASIS 52 0.0040
74 DERMATITIS CONTACT 45 0.0039
75 MAJOR DEPRESSION 28 0.0038
76 HALLUCINATIONS, MIXED 16 0.0038
77 OCULAR DISCOMFORT 42 0.0037
78 ALCOHOL ABUSE 10 0.0037
79 HAEMOGLOBIN INCREASED 17 0.0037
80 VITAMIN D DEFICIENCY 36 0.0037
81 CLONUS 10 0.0037
82 MULTIPLE DRUG OVERDOSE 18 0.0036
83 GLUCOSE TOLERANCE IMPAIRED 21 0.0035
84 OBSTRUCTION 14 0.0035
85 TACHYPHRENIA 12 0.0035
86 VITAMIN B12 DEFICIENCY 14 0.0035
87 HOMICIDAL IDEATION 14 0.0034
88 NECK SURGERY 8 0.0034
89 MULTIPLE DRUG OVERDOSE INTENTIONAL 11 0.0034
90 INGROWING NAIL 8 0.0034
91 OBSESSIVE-COMPULSIVE DISORDER 27 0.0034
92 SINUS OPERATION 8 0.0034
93 HYSTERECTOMY 29 0.0033
94 EYE CONTUSION 7 0.0033
95 REBOUND ACID HYPERSECRETION 10 0.0033
96 CRANIOCEREBRAL INJURY 10 0.0033
97 BRONCHITIS CHRONIC 8 0.0033
98 OBESITY 52 0.0033
99 EOSINOPHILIC OESOPHAGITIS 9 0.0032
100 CARPAL TUNNEL SYNDROME 45 0.0032
101 SURGERY 186 0.0032
102 OXYGEN SATURATION ABNORMAL 9 0.0032
103 IMPAIRED GASTRIC EMPTYING 43 0.0032
104 BEHAVIOUR DISORDER 17 0.0031
105 DIABETIC COMPLICATION 8 0.0031
106 PANIC DISORDER 12 0.0031
107 FEELING DRUNK 23 0.0031
108 DRUG USE DISORDER 26 0.0031
109 AFFECTIVE DISORDER 24 0.0030
110 INTERVERTEBRAL DISC DEGENERATION 28 0.0030
111 GRANULOCYTOPENIA 17 0.0030
112 GAMBLING DISORDER 8 0.0030
113 COMPLETED SUICIDE 246 0.0029
114 DRUG SCREEN FALSE POSITIVE 8 0.0029
115 HYPERREFLEXIA 10 0.0029
116 HYPERLIPIDAEMIA 34 0.0028
117 INTENTIONAL DOSE OMISSION 81 0.0028
118 FIBROMYALGIA 69 0.0028
119 SINUS DISORDER 56 0.0028
120 HORDEOLUM 12 0.0028
121 HIP SURGERY 15 0.0028
122 HYPERTONIC BLADDER 8 0.0028
123 SKIN ABRASION 13 0.0027
124 SUICIDAL IDEATION 248 0.0027
125 POISONING 34 0.0027
126 IRRITABLE BOWEL SYNDROME 58 0.0027
127 TYPE 2 DIABETES MELLITUS 91 0.0027
128 ANXIETY DISORDER 9 0.0027
129 PANIC ATTACK 98 0.0027
130 CHOLECYSTITIS CHRONIC 18 0.0027
131 ATYPICAL PNEUMONIA 8 0.0027
132 CHRONIC SINUSITIS 10 0.0027
133 VITAMIN D DECREASED 22 0.0026
134 APPENDICECTOMY 9 0.0025
135 EAR INFECTION 67 0.0025
136 SINUSITIS 258 0.0025
137 ENDOMETRIOSIS 12 0.0025
138 SINUS CONGESTION 34 0.0025
139 FACIAL BONES FRACTURE 9 0.0025
140 MATERNAL EXPOSURE DURING BREAST FEEDING 10 0.0025
141 POOR QUALITY SLEEP 53 0.0025
142 HEREDITARY ANGIOEDEMA 26 0.0024
143 RESTLESS LEGS SYNDROME 44 0.0024
144 ANXIETY 683 0.0024
145 ANKLE FRACTURE 37 0.0024
146 THERAPEUTIC RESPONSE UNEXPECTED 107 0.0024
147 CATHETER SITE INFECTION 9 0.0024
148 DECREASED INTEREST 14 0.0024
149 CHOLECYSTECTOMY 27 0.0024
150 BRAIN FOG 37 0.0024
151 UPPER RESPIRATORY TRACT INFECTION 109 0.0024
152 FEELING OF DESPAIR 11 0.0024
153 PURULENT DISCHARGE 10 0.0023
154 TYPE 1 DIABETES MELLITUS 14 0.0023
155 HYPERCAPNIA 7 0.0023
156 EMERGENCY CARE 7 0.0023
157 SKIN LACERATION 25 0.0023
158 TENSION 14 0.0023
159 SKIN HAEMORRHAGE 34 0.0023
160 LIMB OPERATION 11 0.0023
161 DISABILITY 45 0.0023
162 RESPIRATORY TRACT INFECTION 59 0.0023
163 PRODUCT DISTRIBUTION ISSUE 21 0.0023
164 APPETITE DISORDER 15 0.0023
165 SCOLIOSIS 14 0.0023
166 MUSCLE TWITCHING 52 0.0023
167 ILLNESS 232 0.0022
168 MIDDLE INSOMNIA 42 0.0022
169 DEPRESSION 510 0.0022
170 OVERWEIGHT 12 0.0022
171 BREATH SOUNDS ABNORMAL 11 0.0022
172 ANGER 75 0.0022
173 PHARYNGITIS STREPTOCOCCAL 24 0.0022
174 RESPIRATORY TRACT CONGESTION 35 0.0022
175 CONCUSSION 17 0.0022
176 DELUSION 34 0.0022
177 SCRATCH 23 0.0022
178 MYOCLONUS 26 0.0022
179 HYPERSOMNIA 62 0.0022
180 NEPHROGENIC ANAEMIA 10 0.0022
181 NEPHROLITHIASIS 99 0.0022
182 ARTHRITIS INFECTIVE 10 0.0022
183 HYPERACUSIS 8 0.0021
184 SKIN FISSURES 42 0.0021
185 SELF-INJURIOUS IDEATION 9 0.0021
186 NOCTURIA 26 0.0021
187 TIBIA FRACTURE 10 0.0021
188 PRODUCT DOSE OMISSION IN ERROR 60 0.0021
189 MENISCUS INJURY 13 0.0021
190 ECONOMIC PROBLEM 32 0.0021
191 THYROID MASS 8 0.0021
192 PANIC REACTION 15 0.0021
193 FOOD ALLERGY 16 0.0021
194 DYSPHEMIA 9 0.0021
195 EUPHORIC MOOD 21 0.0020
196 TOOTH INFECTION 27 0.0020
197 ORAL INFECTION 8 0.0020
198 LIMB INJURY 55 0.0020
199 DRUG EFFECT LESS THAN EXPECTED 30 0.0020
200 MIGRAINE 192 0.0020
201 HUNGER 28 0.0020
202 HIATUS HERNIA 26 0.0020
203 IRON DEFICIENCY 9 0.0020
204 BRONCHITIS 148 0.0020
205 PRODUCT PREPARATION ISSUE 13 0.0020
206 STREPTOCOCCAL INFECTION 11 0.0020
207 SPINAL OPERATION 24 0.0019
208 ROTATOR CUFF SYNDROME 25 0.0019
209 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
210 ROSACEA 9 0.0019
211 ACCIDENT 23 0.0019
212 MUSCLE RIGIDITY 23 0.0019
213 EYE PAIN 108 0.0019
214 DISTURBANCE IN ATTENTION 103 0.0019
215 SPINAL COLUMN STENOSIS 9 0.0019
216 STRESS CARDIOMYOPATHY 11 0.0019
217 ARTHROPOD BITE 14 0.0019
218 TOOTH DISORDER 42 0.0019
219 RESPIRATION ABNORMAL 13 0.0019
220 INTERVERTEBRAL DISC PROTRUSION 41 0.0019
221 SHOULDER OPERATION 8 0.0019
222 ALCOHOLISM 8 0.0019
223 TENSION HEADACHE 8 0.0019
224 MUSCULOSKELETAL DISCOMFORT 32 0.0019
225 PARANOIA 32 0.0019
226 AUTOIMMUNE THYROIDITIS 7 0.0018
227 SINUS HEADACHE 11 0.0018
228 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19 0.0018
229 SKIN SWELLING 16 0.0018
230 CHAPPED LIPS 8 0.0018
231 JOINT INJURY 39 0.0018
232 LIGAMENT SPRAIN 18 0.0018
233 OXYGEN SATURATION DECREASED 102 0.0018
234 HEART RATE ABNORMAL 10 0.0018
235 FACIAL PAIN 16 0.0018
236 BACK DISORDER 29 0.0018
237 POSTOPERATIVE WOUND INFECTION 12 0.0018
238 GASTROENTERITIS VIRAL 32 0.0018
239 OROPHARYNGEAL DISCOMFORT 16 0.0018
240 NEUROLEPTIC MALIGNANT SYNDROME 21 0.0018
241 INFUSION SITE EXTRAVASATION 11 0.0018
242 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 30 0.0018
243 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
244 TEMPERATURE INTOLERANCE 18 0.0017
245 CARDIAC MURMUR 15 0.0017
246 NERVE COMPRESSION 16 0.0017
247 KIDNEY INFECTION 34 0.0017
248 TREMOR 287 0.0017
249 FOREIGN BODY SENSATION IN EYES 11 0.0017
250 MALABSORPTION 9 0.0017
251 RALES 10 0.0017
252 WEIGHT FLUCTUATION 18 0.0017
253 RESPIRATORY ARREST 47 0.0017
254 UPPER-AIRWAY COUGH SYNDROME 14 0.0017
255 DYSPNOEA EXERTIONAL 64 0.0017
256 PRODUCTIVE COUGH 81 0.0017
257 PRODUCT DOSE OMISSION ISSUE 497 0.0017
258 APNOEA 13 0.0017
259 DECREASED ACTIVITY 18 0.0017
260 BACK INJURY 18 0.0017
261 NIGHTMARE 57 0.0016
262 HEAD INJURY 52 0.0016
263 SEDATION 43 0.0016
264 RETCHING 35 0.0016
265 MANIA 27 0.0016
266 DIABETES MELLITUS 125 0.0016
267 TOOTH FRACTURE 18 0.0016
268 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 85 0.0016
269 DRUG DIVERSION 10 0.0016
270 GASTROOESOPHAGEAL REFLUX DISEASE 130 0.0016
271 BLADDER DISORDER 16 0.0016
272 BLOOD PRESSURE ABNORMAL 32 0.0016
273 AGITATION 118 0.0016
274 BLOOD IRON DECREASED 19 0.0016
275 CANDIDA INFECTION 27 0.0016
276 PHOTOPHOBIA 30 0.0016
277 SPINAL OSTEOARTHRITIS 14 0.0016
278 ASTHMA 180 0.0016
279 PERIORBITAL SWELLING 9 0.0016
280 PAIN IN JAW 45 0.0016
281 POISONING DELIBERATE 15 0.0016
282 APHONIA 22 0.0016
283 UNEVALUABLE EVENT 119 0.0016
284 THERAPEUTIC RESPONSE SHORTENED 52 0.0016
285 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
286 BLOOD CHOLESTEROL INCREASED 73 0.0016
287 AFFECT LABILITY 15 0.0016
288 THERMAL BURN 11 0.0015
289 TRISMUS 8 0.0015
290 POOR VENOUS ACCESS 16 0.0015
291 HYPOVOLAEMIA 9 0.0015
292 COELIAC DISEASE 15 0.0015
293 BRADYKINESIA 9 0.0015
294 PSYCHOTIC DISORDER 45 0.0015
295 FEELING JITTERY 29 0.0015
296 NEURALGIA 37 0.0015
297 FOOD CRAVING 8 0.0015
298 PULMONARY ARTERIAL HYPERTENSION 22 0.0015
299 NYSTAGMUS 8 0.0015
300 COORDINATION ABNORMAL 21 0.0015
301 SCIATICA 24 0.0015
302 PHARYNGOLARYNGEAL PAIN 8 0.0015
303 URINARY TRACT INFECTION 255 0.0015
304 FOOD POISONING 8 0.0015
305 RESPIRATORY SYNCYTIAL VIRUS INFECTION 13 0.0015
306 TOOTHACHE 27 0.0015
307 PSYCHIATRIC SYMPTOM 11 0.0015
308 FRUSTRATION TOLERANCE DECREASED 12 0.0015
309 GINGIVITIS 8 0.0015
310 INGUINAL HERNIA 9 0.0015
311 KNEE ARTHROPLASTY 31 0.0015
312 DRUG TOXICITY 20 0.0015
313 BLOOD TESTOSTERONE DECREASED 10 0.0015
314 NONSPECIFIC REACTION 8 0.0015
315 INFLUENZA 162 0.0015
316 HUMERUS FRACTURE 7 0.0015
317 CHOKING SENSATION 8 0.0014
318 GASTROINTESTINAL INFECTION 13 0.0014
319 HYPERCHOLESTEROLAEMIA 14 0.0014
320 HEPATIC STEATOSIS 27 0.0014
321 ABNORMAL DREAMS 40 0.0014
322 DENTAL CARIES 16 0.0014
323 HALLUCINATION 109 0.0014
324 LYMPHOEDEMA 10 0.0014
325 DERMATITIS ATOPIC 76 0.0014
326 PARKINSONISM 14 0.0014
327 ORAL HERPES 28 0.0014
328 TASTE DISORDER 29 0.0014
329 PRODUCT LEAKAGE 8 0.0014
330 MENTAL DISORDER 62 0.0014
331 HEPATOMEGALY 14 0.0014
332 FOOT OPERATION 7 0.0014
333 GASTROINTESTINAL SOUNDS ABNORMAL 7 0.0014
334 HAND FRACTURE 10 0.0014
335 EATING DISORDER 30 0.0014
336 IMPAIRED DRIVING ABILITY 16 0.0014
337 POST PROCEDURAL COMPLICATION 27 0.0014
338 MICTURITION URGENCY 16 0.0014
339 OVARIAN CYST 14 0.0014
340 SOMNOLENCE 282 0.0014
341 BLOOD POTASSIUM DECREASED 42 0.0014
342 VISUAL DISTURBANCE 8 0.0014
343 EMPHYSEMA 14 0.0014
344 RESPIRATORY DEPRESSION 17 0.0014
345 CARDIOMEGALY 17 0.0014
346 FEELING ABNORMAL 331 0.0014
347 NERVOUSNESS 72 0.0014
348 FOOT FRACTURE 26 0.0014
349 APATHY 20 0.0014
350 NIGHT SWEATS 44 0.0014
351 WALKING AID USER 9 0.0014
352 FEELING OF BODY TEMPERATURE CHANGE 8 0.0014
353 INCREASED APPETITE 26 0.0014
354 ADVERSE REACTION 18 0.0014
355 DIABETES MELLITUS INADEQUATE CONTROL 24 0.0014
356 LOWER LIMB FRACTURE 26 0.0014
357 EXPOSURE VIA SKIN CONTACT 35 0.0013
358 GALLBLADDER DISORDER 24 0.0013
359 SCAR 23 0.0013
360 THINKING ABNORMAL 25 0.0013
361 BREAST MASS 9 0.0013
362 HICCUPS 11 0.0013
363 COVID-19 235 0.0013
364 ROAD TRAFFIC ACCIDENT 56 0.0013
365 SKIN INFECTION 15 0.0013
366 ANAL INCONTINENCE 12 0.0013
367 MENTAL STATUS CHANGES 37 0.0013
368 BALANCE DISORDER 115 0.0013
369 PHARYNGEAL SWELLING 13 0.0013
370 EYE INFECTION 15 0.0013
371 BLOOD SODIUM DECREASED 25 0.0013
372 DRY EYE 66 0.0013
373 WEIGHT INCREASED 296 0.0013
374 IMPAIRED QUALITY OF LIFE 19 0.0013
375 BLOOD PRESSURE INCREASED 202 0.0013
376 SUICIDE ATTEMPT 80 0.0013
377 COUGH 368 0.0013
378 DRUG ABUSER 8 0.0013
379 BLOOD TRIGLYCERIDES INCREASED 23 0.0013
380 IRON DEFICIENCY ANAEMIA 12 0.0013
381 SALIVARY HYPERSECRETION 13 0.0013
382 DRY MOUTH 105 0.0013
383 FALL 429 0.0013
384 INSOMNIA 343 0.0013
385 RESTLESSNESS 47 0.0013
386 PULMONARY THROMBOSIS 14 0.0013
387 HEART RATE INCREASED 127 0.0013
388 BODY TEMPERATURE INCREASED 26 0.0013
389 MUSCLE STRAIN 11 0.0013
390 POLLAKIURIA 53 0.0013
391 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 61 0.0013
392 SPINAL DISORDER 12 0.0013
393 SPUTUM DISCOLOURED 12 0.0013
394 DIVERTICULITIS 35 0.0013
395 NASAL DISCOMFORT 10 0.0013
396 PRODUCT SUPPLY ISSUE 9 0.0013
397 AMNESIA 82 0.0013
398 NASAL CONGESTION 74 0.0013
399 ABDOMINAL DISCOMFORT 211 0.0013
400 EYE DISCHARGE 13 0.0012
401 CHRONIC KIDNEY DISEASE 95 0.0012
402 BACK PAIN 290 0.0012
403 ATELECTASIS 12 0.0012
404 TARDIVE DYSKINESIA 35 0.0012
405 FLUSHING 126 0.0012
406 HEART RATE IRREGULAR 28 0.0012
407 FLUID RETENTION 63 0.0012
408 PERIPHERAL COLDNESS 17 0.0012
409 EAR PAIN 24 0.0012
410 OROPHARYNGEAL PAIN 114 0.0012
411 THIRST 22 0.0012
412 IRRITABILITY 74 0.0012
413 MUSCULOSKELETAL CHEST PAIN 19 0.0012
414 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
415 GASTRITIS 32 0.0012
416 NEUROPATHY PERIPHERAL 115 0.0012
417 IMMUNODEFICIENCY 18 0.0012
418 TOOTH EXTRACTION 15 0.0012
419 THROAT IRRITATION 54 0.0012
420 HYPERHIDROSIS 155 0.0012
421 HEADACHE 753 0.0012
422 MEMORY IMPAIRMENT 165 0.0012
423 FUNGAL INFECTION 40 0.0012
424 INTENTIONAL PRODUCT USE ISSUE 105 0.0012
425 PNEUMOTHORAX 19 0.0012
426 COMA 57 0.0012
427 HALLUCINATION, AUDITORY 19 0.0012
428 OSTEOPENIA 18 0.0012
429 NEPHROPATHY 11 0.0012
430 DEPRESSED MOOD 62 0.0012
431 NASOPHARYNGITIS 216 0.0012
432 EAR DISCOMFORT 12 0.0012
433 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
434 CYSTITIS 37 0.0012
435 DRY SKIN 155 0.0012
436 DROOLING 8 0.0012
437 CRYING 42 0.0012
438 BONE DISORDER 21 0.0012
439 PULMONARY HYPERTENSION 24 0.0012
440 GASTROINTESTINAL INFLAMMATION 9 0.0011
441 GENERALISED TONIC-CLONIC SEIZURE 19 0.0011
442 CARDIO-RESPIRATORY ARREST 48 0.0011
443 WHEEZING 68 0.0011
444 WITHDRAWAL SYNDROME 48 0.0011
445 PULMONARY MASS 17 0.0011
446 WEIGHT DECREASED 318 0.0011
447 GROIN PAIN 10 0.0011
448 HERNIA 22 0.0011
449 SMALL INTESTINAL OBSTRUCTION 14 0.0011
450 PERIPHERAL SWELLING 175 0.0011
451 DIZZINESS POSTURAL 11 0.0011
452 DYSKINESIA 46 0.0011
453 LOSS OF CONSCIOUSNESS 145 0.0011
454 AUTOIMMUNE DISORDER 11 0.0011
455 ATRIAL FLUTTER 9 0.0011
456 EXTRAPYRAMIDAL DISORDER 28 0.0011
457 URINARY INCONTINENCE 33 0.0011
458 PRESYNCOPE 27 0.0011
459 PALPITATIONS 130 0.0011
460 SEXUAL DYSFUNCTION 13 0.0011
461 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
462 BLOOD URINE PRESENT 21 0.0011
463 SUBSTANCE ABUSE 9 0.0011
464 TONGUE DISORDER 8 0.0011
465 ANHEDONIA 29 0.0011
466 NECK PAIN 61 0.0011
467 THERAPY PARTIAL RESPONDER 17 0.0011
468 OSTEOARTHRITIS 46 0.0011
469 UNRESPONSIVE TO STIMULI 28 0.0011
470 WRIST FRACTURE 13 0.0011
471 BLOOD PRESSURE FLUCTUATION 26 0.0011
472 GRAND MAL CONVULSION 10 0.0011
473 VIRAL INFECTION 36 0.0011
474 CEREBRAL DISORDER 8 0.0011
475 CONJUNCTIVITIS 20 0.0011
476 LOCALISED INFECTION 26 0.0011
477 DYSPNOEA 608 0.0011
478 ULCER 17 0.0011
479 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 192 0.0011
480 PRODUCT USE IN UNAPPROVED INDICATION 264 0.0011
481 DYSGRAPHIA 7 0.0011
482 HYPERTENSION 225 0.0011
483 STAPHYLOCOCCAL INFECTION 35 0.0011
484 DISORIENTATION 42 0.0011
485 CONTUSION 102 0.0011
486 TACHYCARDIA 94 0.0011
487 FACIAL PARALYSIS 9 0.0011
488 FATIGUE 822 0.0011
489 ARTHRITIS 83 0.0011
490 HOSPITALISATION 162 0.0011
491 DEVICE FAILURE 16 0.0010
492 DIZZINESS 523 0.0010
493 SLEEP DISORDER 74 0.0010
494 NAUSEA 828 0.0010
495 INJECTION SITE RASH 32 0.0010
496 PSYCHOLOGICAL TRAUMA 9 0.0010
497 THYROID DISORDER 16 0.0010
498 DELIRIUM 36 0.0010
499 DYSPEPSIA 102 0.0010
500 RHINORRHOEA 67 0.0010
501 VISION BLURRED 142 0.0010
502 PRODUCT TASTE ABNORMAL 14 0.0010
503 ORTHOSTATIC HYPOTENSION 18 0.0010
504 VERTIGO 63 0.0010
505 CELLULITIS 52 0.0010
506 CHEST PAIN 191 0.0010
507 MOOD ALTERED 28 0.0010
508 LACRIMATION INCREASED 31 0.0010
509 INJECTION SITE IRRITATION 13 0.0010
510 DRUG ABUSE 85 0.0010
511 KNEE OPERATION 10 0.0010
512 GASTROINTESTINAL DISORDER 91 0.0010
513 HOSPICE CARE 10 0.0010
514 ATAXIA 12 0.0010
515 CONDITION AGGRAVATED 307 0.0010
516 TRICUSPID VALVE INCOMPETENCE 8 0.0010
517 CHEST DISCOMFORT 103 0.0010
518 EMOTIONAL DISORDER 31 0.0010
519 MACULAR DEGENERATION 12 0.0010
520 UPPER LIMB FRACTURE 20 0.0010
521 PANCREATITIS 53 0.0010
522 TINNITUS 46 0.0010
523 AGGRESSION 50 0.0010
524 SPINAL FRACTURE 20 0.0010
525 INFLUENZA LIKE ILLNESS 82 0.0010
526 LEUKOCYTOSIS 18 0.0010
527 BLOOD PRESSURE DECREASED 66 0.0010
528 DYSPHONIA 58 0.0010
529 MYASTHENIA GRAVIS 8 0.0010
530 DRUG INTERACTION 157 0.0010
531 ACUTE RESPIRATORY FAILURE 19 0.0010
532 FLATULENCE 56 0.0010
533 ORAL CANDIDIASIS 13 0.0010
534 END STAGE RENAL DISEASE 18 0.0010
535 GLAUCOMA 19 0.0010
536 FEEDING DISORDER 20 0.0010
537 EXOSTOSIS 9 0.0010
538 PAIN 605 0.0010
539 DRY THROAT 10 0.0010
540 CONFUSIONAL STATE 159 0.0010
541 POST PROCEDURAL INFECTION 8 0.0010
542 DECUBITUS ULCER 8 0.0010
543 MOTOR DYSFUNCTION 10 0.0010
544 THERAPY INTERRUPTED 70 0.0010
545 BLOOD CALCIUM DECREASED 11 0.0010
546 NEUTROPHIL COUNT INCREASED 10 0.0010
547 PRURITUS 375 0.0010
548 PRODUCT PREPARATION ERROR 20 0.0010
549 OSTEOPOROSIS 40 0.0010
550 RIB FRACTURE 20 0.0010
551 HYPOTHYROIDISM 31 0.0010
552 MUSCULOSKELETAL STIFFNESS 85 0.0010
553 TENDONITIS 15 0.0010
554 SPINAL COMPRESSION FRACTURE 8 0.0010
555 HYPOXIA 34 0.0010
556 COLD SWEAT 17 0.0010
557 COMPLICATION ASSOCIATED WITH DEVICE 14 0.0010
558 PNEUMONIA 311 0.0010
559 GASTROENTERITIS 14 0.0010
560 DYSARTHRIA 36 0.0010
561 ARTERIOSCLEROSIS 9 0.0010
562 LETHARGY 55 0.0010
563 DECREASED APPETITE 222 0.0010
564 DYSURIA 35 0.0009
565 HALLUCINATION, VISUAL 20 0.0009
566 ELECTROLYTE IMBALANCE 11 0.0009
567 INCONTINENCE 10 0.0009
568 DEHYDRATION 126 0.0009
569 ECZEMA 49 0.0009
570 FEAR 25 0.0009
571 HYPOAESTHESIA ORAL 14 0.0009
572 MUSCLE TIGHTNESS 15 0.0009
573 SKIN EXFOLIATION 78 0.0009
574 MUSCLE SPASMS 169 0.0009
575 ABDOMINAL DISTENSION 96 0.0009
576 HYPERTHERMIA 7 0.0009
577 HYPOAESTHESIA 137 0.0009
578 TREATMENT NONCOMPLIANCE 50 0.0009
579 IMMUNE SYSTEM DISORDER 12 0.0009
580 PULMONARY CONGESTION 12 0.0009
581 PURPURA 8 0.0009
582 COGNITIVE DISORDER 42 0.0009
583 NERVE INJURY 10 0.0009
584 FEELING COLD 25 0.0009
585 GOUT 16 0.0009
586 SYNCOPE 89 0.0009
587 HYPOTHERMIA 9 0.0009
588 INTENTIONAL OVERDOSE 57 0.0009
589 GAIT DISTURBANCE 170 0.0009
590 EYE SWELLING 33 0.0009
591 TOOTH ABSCESS 9 0.0009
592 FURUNCLE 7 0.0009
593 PAIN IN EXTREMITY 260 0.0009
594 SLUGGISHNESS 9 0.0009
595 CONSTIPATION 192 0.0009
596 GINGIVAL PAIN 7 0.0009
597 HIDRADENITIS 8 0.0009
598 SEIZURE 101 0.0009
599 CHOKING 17 0.0009
600 BRAIN OEDEMA 11 0.0009
601 NEOPLASM 10 0.0009
602 EPISTAXIS 65 0.0009
603 GAIT INABILITY 29 0.0009
604 OEDEMA 47 0.0009
605 PROCEDURAL PAIN 24 0.0009
606 ARTHROPATHY 48 0.0009
607 ORAL DISCOMFORT 12 0.0009
608 BLOOD POTASSIUM INCREASED 14 0.0009
609 HYPOMAGNESAEMIA 12 0.0009
610 OEDEMA PERIPHERAL 105 0.0009
611 HAEMOPTYSIS 24 0.0009
612 ABNORMAL BEHAVIOUR 34 0.0009
613 BLOOD TEST ABNORMAL 12 0.0009
614 SPLENOMEGALY 10 0.0009
615 JOINT DISLOCATION 9 0.0009
616 HIP ARTHROPLASTY 13 0.0008
617 DRUG LEVEL INCREASED 14 0.0008
618 SINUS TACHYCARDIA 12 0.0008
619 ARTHRALGIA 350 0.0008
620 BODY HEIGHT DECREASED 9 0.0008
621 ABDOMINAL PAIN UPPER 173 0.0008
622 HIP FRACTURE 27 0.0008
623 CARDIOGENIC SHOCK 12 0.0008
624 CHILLS 98 0.0008
625 CARDIAC ARREST 69 0.0008
626 HERPES ZOSTER 48 0.0008
627 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
628 EYE PRURITUS 28 0.0008
629 PRURITUS GENERALISED 18 0.0008
630 PARAESTHESIA ORAL 12 0.0008
631 CORONARY ARTERY DISEASE 25 0.0008
632 DYSTONIA 16 0.0008
633 THERAPEUTIC RESPONSE DECREASED 50 0.0008
634 VISUAL IMPAIRMENT 102 0.0008
635 CATARACT 49 0.0008
636 HOT FLUSH 62 0.0008
637 HYPOTENSION 165 0.0008
638 DYSSTASIA 24 0.0008
639 WOUND INFECTION 9 0.0008
640 CARDIAC FAILURE CONGESTIVE 66 0.0008
641 SPEECH DISORDER 43 0.0008
642 QUALITY OF LIFE DECREASED 11 0.0008
643 LUNG DISORDER 40 0.0008
644 FEELING HOT 50 0.0008
645 INJECTION SITE URTICARIA 20 0.0008
646 DIARRHOEA 526 0.0008
647 SENSORY DISTURBANCE 13 0.0008
648 MALAISE 355 0.0008
649 DIPLOPIA 21 0.0008
650 AKATHISIA 11 0.0008
651 CYST 10 0.0008
652 INABILITY TO AFFORD MEDICATION 8 0.0008
653 HEPATIC CIRRHOSIS 15 0.0008
654 INJURY 56 0.0008
655 SWELLING 74 0.0008
656 PRODUCT AVAILABILITY ISSUE 18 0.0008
657 MUSCLE ATROPHY 10 0.0008
658 DEMENTIA 22 0.0008
659 BURNING SENSATION 55 0.0008
660 PSYCHOMOTOR HYPERACTIVITY 13 0.0008
661 MUSCULAR WEAKNESS 89 0.0008
662 VOMITING 368 0.0008
663 PARAESTHESIA 123 0.0008
664 INFECTION 113 0.0008
665 PRODUCT DISPENSING ERROR 17 0.0008
666 THERAPY NON-RESPONDER 35 0.0008
667 LIMB DISCOMFORT 24 0.0008
668 PRESCRIBED OVERDOSE 15 0.0008
669 SKIN ULCER 20 0.0008
670 RASH MACULAR 27 0.0008
671 INJECTION SITE PAIN 236 0.0008
672 HAEMORRHOIDS 15 0.0008
673 RHABDOMYOLYSIS 32 0.0008
674 PLATELET COUNT INCREASED 10 0.0008
675 SKIN LESION 21 0.0008
676 PRODUCT ODOUR ABNORMAL 8 0.0008
677 CYANOSIS 12 0.0008
678 CHOLELITHIASIS 25 0.0008
679 COVID-19 PNEUMONIA 9 0.0008
680 AGEUSIA 19 0.0008
681 RESPIRATORY DISTRESS 21 0.0008
682 HYPOKINESIA 11 0.0008
683 HYPERSENSITIVITY 140 0.0008
684 BREAST PAIN 8 0.0007
685 EYE HAEMORRHAGE 10 0.0007
686 THROMBOSIS 60 0.0007
687 HEPATITIS C 9 0.0007
688 CARDIOMYOPATHY 11 0.0007
689 INTESTINAL OBSTRUCTION 28 0.0007
690 ADRENAL INSUFFICIENCY 9 0.0007
691 HYPERGLYCAEMIA 27 0.0007
692 CARDIAC DISORDER 69 0.0007
693 JOINT SWELLING 89 0.0007
694 HEAD DISCOMFORT 13 0.0007
695 RENAL FAILURE 97 0.0007
696 EYE IRRITATION 42 0.0007
697 ADVERSE DRUG REACTION 65 0.0007
698 HAIR COLOUR CHANGES 9 0.0007
699 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
700 RHEUMATOID ARTHRITIS 82 0.0007
701 FOOT DEFORMITY 8 0.0007
702 PNEUMONIA ASPIRATION 18 0.0007
703 VENTRICULAR FIBRILLATION 8 0.0007
704 HEPATIC ENZYME INCREASED 49 0.0007
705 SECRETION DISCHARGE 9 0.0007
706 INJECTION SITE SWELLING 55 0.0007
707 INTENTIONAL DRUG MISUSE 15 0.0007
708 INJECTION SITE PRURITUS 48 0.0007
709 OCULAR HYPERAEMIA 34 0.0007
710 PULMONARY OEDEMA 32 0.0007
711 ORAL PAIN 16 0.0007
712 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
713 HAEMATEMESIS 18 0.0007
714 BLINDNESS UNILATERAL 10 0.0007
715 BLOOD GLUCOSE DECREASED 34 0.0007
716 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
717 RENAL INJURY 21 0.0007
718 DRUG WITHDRAWAL SYNDROME 62 0.0007
719 NERVOUS SYSTEM DISORDER 22 0.0007
720 ASTHENIA 264 0.0007
721 PRODUCT USE COMPLAINT 11 0.0007
722 BRAIN INJURY 7 0.0007
723 DYSPHAGIA 66 0.0007
724 FULL BLOOD COUNT DECREASED 14 0.0007
725 DEEP VEIN THROMBOSIS 45 0.0007
726 FAECES DISCOLOURED 15 0.0007
727 PRODUCT USE ISSUE 130 0.0007
728 SKIN DISORDER 23 0.0007
729 MADAROSIS 8 0.0007
730 DEAFNESS 18 0.0007
731 MYALGIA 117 0.0007
732 TOXICITY TO VARIOUS AGENTS 116 0.0007
733 HYPOCALCAEMIA 13 0.0007
734 FRACTURE 13 0.0007
735 JOINT STIFFNESS 18 0.0007
736 MOVEMENT DISORDER 22 0.0007
737 BEDRIDDEN 9 0.0007
738 ANKYLOSING SPONDYLITIS 9 0.0007
739 BONE PAIN 40 0.0007
740 SPINAL PAIN 8 0.0007
741 LYMPHOCYTE COUNT DECREASED 12 0.0007
742 HAIR TEXTURE ABNORMAL 9 0.0007
743 CHOLECYSTITIS 8 0.0007
744 SNEEZING 15 0.0007
745 PAIN OF SKIN 18 0.0007
746 DERMATITIS 14 0.0007
747 RASH 291 0.0007
748 THROAT TIGHTNESS 18 0.0007
749 THYROID CANCER 8 0.0007
750 MOUTH ULCERATION 14 0.0007
751 INTENTIONAL PRODUCT MISUSE 58 0.0007
752 CONTRAINDICATED PRODUCT ADMINISTERED 20 0.0007
753 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
754 BURSITIS 8 0.0007
755 PRODUCT DOSE OMISSION 43 0.0007
756 SCHIZOPHRENIA 8 0.0007
757 HAEMATOMA 17 0.0007
758 PHARMACEUTICAL PRODUCT COMPLAINT 17 0.0007
759 INJECTION SITE BRUISING 52 0.0007
760 MUSCLE SPASTICITY 8 0.0007
761 BLOOD GLUCOSE ABNORMAL 12 0.0006
762 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
763 RASH PRURITIC 35 0.0006
764 PHARYNGITIS 8 0.0006
765 INTENTIONAL SELF-INJURY 13 0.0006
766 GASTRIC DISORDER 22 0.0006
767 DEVICE OCCLUSION 9 0.0006
768 ATRIAL FIBRILLATION 62 0.0006
769 PYREXIA 218 0.0006
770 PARALYSIS 9 0.0006
771 MOOD SWINGS 20 0.0006
772 HEART RATE DECREASED 22 0.0006
773 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
774 ERUCTATION 12 0.0006
775 PSORIATIC ARTHROPATHY 25 0.0006
776 NODULE 8 0.0006
777 CONVULSION 35 0.0006
778 SWOLLEN TONGUE 19 0.0006
779 OSTEOMYELITIS 11 0.0006
780 HYPOKALAEMIA 28 0.0006
781 MULTIPLE SCLEROSIS 29 0.0006
782 SARS-COV-2 TEST POSITIVE 8 0.0006
783 DYSMENORRHOEA 8 0.0006
784 RESPIRATORY DISORDER 18 0.0006
785 MULTIPLE SCLEROSIS RELAPSE 41 0.0006
786 BLOOD UREA INCREASED 10 0.0006
787 APHASIA 18 0.0006
788 PRODUCT ADMINISTRATION ERROR 12 0.0006
789 SYSTEMIC LUPUS ERYTHEMATOSUS 21 0.0006
790 HEMIPARESIS 10 0.0006
791 BACTERAEMIA 7 0.0006
792 RESPIRATORY FAILURE 43 0.0006
793 HYPOPHAGIA 15 0.0006
794 DEVICE RELATED INFECTION 9 0.0006
795 CORONARY ARTERY OCCLUSION 8 0.0006
796 GASTRIC ULCER 11 0.0006
797 WRONG TECHNIQUE IN DRUG USAGE PROCESS 21 0.0006
798 DEVICE DISLOCATION 25 0.0006
799 MASS 8 0.0006
800 MOBILITY DECREASED 41 0.0006
801 BLISTER 32 0.0006
802 URINARY RETENTION 19 0.0006
803 GENERALISED OEDEMA 7 0.0006
804 INFLAMMATION 29 0.0006
805 IMPAIRED WORK ABILITY 12 0.0006
806 BRONCHOSPASM 8 0.0006
807 STOMATITIS 34 0.0006
808 RED BLOOD CELL COUNT DECREASED 16 0.0006
809 RENAL DISORDER 26 0.0006
810 PULMONARY EMBOLISM 53 0.0006
811 SKIN CANCER 12 0.0006
812 DISCOMFORT 34 0.0006
813 HAEMATOCRIT DECREASED 11 0.0006
814 ABDOMINAL PAIN 129 0.0006
815 ABDOMINAL PAIN LOWER 14 0.0006
816 SWELLING FACE 36 0.0006
817 ACUTE KIDNEY INJURY 84 0.0005
818 EYE DISORDER 18 0.0005
819 EXPOSURE DURING PREGNANCY 34 0.0005
820 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 30 0.0005
821 PRODUCT PRESCRIBING ERROR 13 0.0005
822 PHOTOSENSITIVITY REACTION 9 0.0005
823 ALOPECIA 107 0.0005
824 ILL-DEFINED DISORDER 33 0.0005
825 EXTRA DOSE ADMINISTERED 22 0.0005
826 DIABETIC KETOACIDOSIS 13 0.0005
827 INJECTION SITE MASS 20 0.0005
828 URTICARIA 90 0.0005
829 WOUND 15 0.0005
830 ERYTHEMA 110 0.0005
831 INJECTION SITE WARMTH 11 0.0005
832 TOOTH LOSS 11 0.0005
833 DRUG INEFFECTIVE 699 0.0005
834 OVERDOSE 114 0.0005
835 INFUSION RELATED REACTION 35 0.0005
836 MUSCULOSKELETAL DISORDER 10 0.0005
837 INJECTION SITE ERYTHEMA 65 0.0005
838 RASH ERYTHEMATOUS 25 0.0005
839 PULMONARY FIBROSIS 10 0.0005
840 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 37 0.0005
841 IMPAIRED HEALING 17 0.0005
842 DEVICE USE ISSUE 9 0.0005
843 HYPOACUSIS 22 0.0005
844 MENORRHAGIA 10 0.0005
845 BRADYCARDIA 27 0.0005
846 INJECTION SITE REACTION 35 0.0005
847 THERAPY CESSATION 26 0.0005
848 ERECTILE DYSFUNCTION 13 0.0005
849 PRODUCT PRESCRIBING ISSUE 11 0.0005
850 CLOSTRIDIUM DIFFICILE INFECTION 11 0.0005
851 SEPSIS 56 0.0005
852 ABSCESS 8 0.0005
853 DRUG EFFECT DECREASED 27 0.0005
854 HYPONATRAEMIA 28 0.0005
855 CEREBROVASCULAR ACCIDENT 84 0.0005
856 MENTAL IMPAIRMENT 12 0.0005
857 DEVICE BREAKAGE 20 0.0005
858 ACCIDENTAL OVERDOSE 18 0.0005
859 WHITE BLOOD CELL COUNT DECREASED 53 0.0005
860 RECTAL HAEMORRHAGE 21 0.0005
861 ANAPHYLACTIC REACTION 27 0.0005
862 PLATELET COUNT DECREASED 52 0.0005
863 ANOSMIA 7 0.0005
864 BACTERIAL INFECTION 9 0.0005
865 LYMPHADENOPATHY 17 0.0005
866 ANAEMIA 91 0.0005
867 LABORATORY TEST ABNORMAL 14 0.0005
868 FACE OEDEMA 8 0.0005
869 EMOTIONAL DISTRESS 57 0.0005
870 COLON CANCER 7 0.0005
871 THERAPEUTIC PRODUCT EFFECT DECREASED 21 0.0005
872 HAEMOGLOBIN DECREASED 48 0.0005
873 BLINDNESS 19 0.0005
874 DRUG DISPENSING ERROR 7 0.0005
875 DYSGEUSIA 34 0.0005
876 ACCIDENTAL EXPOSURE TO PRODUCT 47 0.0005
877 DRUG INTOLERANCE 44 0.0005
878 ANGINA PECTORIS 13 0.0005
879 ACUTE RESPIRATORY DISTRESS SYNDROME 8 0.0005
880 EXPIRED PRODUCT ADMINISTERED 15 0.0005
881 PRESCRIBED UNDERDOSE 9 0.0005
882 EJECTION FRACTION DECREASED 7 0.0004
883 ACNE 34 0.0004
884 LIVER FUNCTION TEST ABNORMAL 13 0.0004
885 INCORRECT DOSE ADMINISTERED 102 0.0004
886 BONE DENSITY DECREASED 14 0.0004
887 ARRHYTHMIA 21 0.0004
888 CHROMATURIA 10 0.0004
889 HAEMORRHAGE 46 0.0004
890 LOWER RESPIRATORY TRACT INFECTION 20 0.0004
891 PSORIASIS 57 0.0004
892 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
893 OFF LABEL USE 379 0.0004
894 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
895 MATERNAL EXPOSURE DURING PREGNANCY 38 0.0004
896 LIP SWELLING 14 0.0004
897 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 85 0.0004
898 SKIN DISCOLOURATION 19 0.0004
899 ENCEPHALOPATHY 10 0.0004
900 FREQUENT BOWEL MOVEMENTS 11 0.0004
901 STEVENS-JOHNSON SYNDROME 9 0.0004
902 PNEUMONITIS 11 0.0004
903 NO ADVERSE EVENT 73 0.0004
904 GLOSSODYNIA 9 0.0004
905 RASH PAPULAR 9 0.0004
906 ADVERSE EVENT 37 0.0004
907 MUSCULOSKELETAL PAIN 21 0.0004
908 INJECTION SITE HAEMORRHAGE 32 0.0004
909 RENAL FAILURE ACUTE 17 0.0004
910 PRODUCT SUBSTITUTION ISSUE 23 0.0004
911 ABORTION SPONTANEOUS 16 0.0004
912 HEPATIC FAILURE 12 0.0004
913 MEDICATION ERROR 22 0.0004
914 COLITIS 15 0.0004
915 MYOCARDIAL INFARCTION 69 0.0004
916 PLEURAL EFFUSION 24 0.0004
917 HYPOGLYCAEMIA 19 0.0004
918 CEREBRAL HAEMORRHAGE 14 0.0004
919 PERICARDIAL EFFUSION 9 0.0004
920 LIVER DISORDER 17 0.0004
921 NEEDLE ISSUE 11 0.0004
922 SKIN BURNING SENSATION 27 0.0004
923 JAUNDICE 10 0.0004
924 BLOOD GLUCOSE INCREASED 70 0.0004
925 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
926 BLOOD CREATININE INCREASED 24 0.0004
927 ABASIA 9 0.0004
928 NEOPLASM MALIGNANT 24 0.0004
929 DRUG EFFECT INCOMPLETE 13 0.0004
930 DEVICE ISSUE 32 0.0004
931 PANCREATITIS ACUTE 8 0.0004
932 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
933 SHOCK 8 0.0003
934 RENAL IMPAIRMENT 29 0.0003
935 ASCITES 10 0.0003
936 CARDIAC FAILURE 27 0.0003
937 SKIN IRRITATION 15 0.0003
938 HAEMATOCHEZIA 18 0.0003
939 FEMUR FRACTURE 10 0.0003
940 DEVICE LEAKAGE 14 0.0003
941 HEPATIC FUNCTION ABNORMAL 12 0.0003
942 LEUKOPENIA 16 0.0003
943 DRUG DOSE OMISSION 52 0.0003
944 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
945 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
946 LACTIC ACIDOSIS 10 0.0003
947 ACUTE MYOCARDIAL INFARCTION 9 0.0003
948 PREMATURE BABY 9 0.0003
949 MENSTRUATION IRREGULAR 8 0.0003
950 PRODUCT QUALITY ISSUE 40 0.0003
951 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
952 ALANINE AMINOTRANSFERASE INCREASED 18 0.0003
953 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
954 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
955 DEATH 243 0.0003
956 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
957 VAGINAL HAEMORRHAGE 12 0.0003
958 SEPTIC SHOCK 12 0.0003
959 ANGIOEDEMA 12 0.0003
960 VISUAL ACUITY REDUCED 9 0.0003
961 DRUG DEPENDENCE 43 0.0003
962 EPILEPSY 8 0.0003
963 DRUG ADMINISTRATION ERROR 8 0.0003
964 BLOOD BILIRUBIN INCREASED 7 0.0003
965 DEVICE USE ERROR 9 0.0003
966 GENERAL PHYSICAL HEALTH DETERIORATION 29 0.0003
967 NEUTROPHIL COUNT DECREASED 10 0.0002
968 THROMBOCYTOPENIA 26 0.0002
969 HYPERKALAEMIA 8 0.0002
970 DEVICE MALFUNCTION 16 0.0002
971 PRODUCT ADHESION ISSUE 8 0.0002
972 COLITIS ULCERATIVE 10 0.0002
973 C-REACTIVE PROTEIN INCREASED 8 0.0002
974 UNDERDOSE 16 0.0002
975 DISEASE RECURRENCE 10 0.0002
976 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
977 PLASMA CELL MYELOMA 8 0.0002
978 HAEMATURIA 7 0.0002
979 FOETAL EXPOSURE DURING PREGNANCY 16 0.0002
980 BREAST CANCER 18 0.0002
981 TREATMENT FAILURE 16 0.0002
982 NEUTROPENIA 23 0.0002
983 DEVICE DIFFICULT TO USE 11 0.0002
984 INTERSTITIAL LUNG DISEASE 8 0.0002
985 DISEASE PROGRESSION 18 0.0002
986 DRUG DOSE OMISSION BY DEVICE 11 0.0001
987 DEVICE EXPULSION 9 0.0001
988 PRODUCT STORAGE ERROR 12 0.0001
989 MALIGNANT NEOPLASM PROGRESSION 12 0.0001